Study of the Safety, Tolerability and Pharmacokinetics of HZ-A-018 in Patients With B Cell Lymphoma

NCT04173455 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, B-Cell

Interventions

DRUG: HZ-A-018

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]